Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Metabolic alteration for adaptation of the local environment has been recognized as a hallmark of cancer. GNPAT dysregulation has been implicated in hepatocellular carcinoma (HCC). However, the precise posttranslational regulation of GNPAT is still undiscovered. Here we show that ACAT1 is upregulated in response to extra palmitic acid (PA). ACAT1 acetylates GNPAT at K128, which represses TRIM21-mediated GNPAT ubiquitination and degradation. Conversely, GNPAT deacetylation by SIRT4 antagonizes ACAT1's function. GNPAT represses TRIM21-mediated FASN degradation and promotes lipid metabolism. Furthermore, shRNA-mediated ACAT1 ablation and acetylation deficiency of GNPAT repress lipid metabolism and tumor progression in xenograft and DEN/CCl 4 -induced HCC. Otherwise, ACAT1 inhibitor combination with sorafenib enormously retards tumor formation in mice. Collectively, we demonstrate that stabilization of FASN by ACAT1-mediated GNPAT acetylation plays a critical role in hepatocarcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“glyceronephosphate O-acyltransferase (GNPAT) is a peroxisomal enzyme implicated in plasmalogen and fatty acid biosynthesis which is acetylated at K128 by mitochondrial acetyltransferase ACAT1 [58].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [58]
In the citing paper
“GNPATK128Ac is therefore responsible for ACAT1-mediated oncogenic phenotypes in hepatocellular carcinoma (HCC) and several other cancers, which consist of increases in lipogenesis and proliferation [58,60].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [58]
In the citing paper
“In combination with approved HCC therapies, ACAT1 inhibitors effectively reduce tumorigenesis in HCC mouse models [58]”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [58]
In the citing paper
“GNPATK128Ac correlates with increased GNPAT stabilization and dimerization by disrupting its ability to bind E3 ligase TRIM21 (Figure 2B) [58].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [58]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 2×
“Fatty acid synthase (FASN) is a critical enzyme for the synthesis of long-chain fatty acids from malonyl-CoA [1] and FASN upregulation has been identified in many cancer types, such as prostate cancer [2], pancreatic cancer [3], breast cancer [4], and colorectal cancer [5].”
BackgroundNAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., Zha, Z., Liu, Y., Li, Z., Xu, Y., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.025 · Cited by 610
Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis
Knobloch, M., Braun, S. M. G., Zurkirchen, L., von Schoultz, C., Zamboni, N., Araúzo-Bravo, M. J., Kovacs, W. J., Karalay, Ö., Suter, U., Machado, R. A. C., et al. (2013) · Nature · doi:10.1038/nature11689 · Cited by 499
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00055-8 · Cited by 367
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Kim, D. W., Talati, C., & Kim, R. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.09.07 · Cited by 333
Cited by
Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, C. W., & Ali, A. (2020) · Molecules · doi:10.3390/molecules25173935 · Cited by 392
“Acetylation can also influence FASN protein stability where an excessive amount of palmitic acid can upregulate acetyl-CoA acetyltransferase 1 (ACAT1), which in turn acetylates glyceronephosphate o-acyltransferase (GNPAT) and represses tripartite motif-containing protein 21 (TRIM21)-mediated FASN degradation during li…”
BackgroundLipid alterations in chronic liver disease and liver cancer
Paul, B., Lewinska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 308
“As such, stabilisation of FASN by glyceronephosphate O-acyltransferase promotes DNL and formation of liver tumours in mice.(212) Interestingly, FASN expression is dispensable for CCA formation in AKT/ Notch intracellular domain 1- and AKT/Ras-driven models,(203) and”
BackgroundProtein acylation: mechanisms, biological functions and therapeutic targets
Shang, S., Liu, J., & Hua, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01245-y · Cited by 235
“The accumulated GNPAT then represses the degradation of fatty acid synthase (FASN) mediated by TRIM21 and promotes fatty acid synthesis and hepatocarcinogenesis.(99) Protein acetylation of the key enzymes in glutamine metabolism or in the TCA cycle is another good example in tumor.”
BackgroundNon-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 116
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Shen, H., Qi, X., Hu, Y., Wang, Y., Zhang, J., Liu, Z., & Qin, Z. (2024) · Theranostics · doi:10.7150/thno.100667 · Cited by 110
“…(ACAT1), a mitochondrial enzyme that acetylates GNPAT at the K128 site, promotes lipid metabolism and hepato-carcinogenesis by stabilizing fatty acid synthase (FASN) metabolism and hepatocarcinogenesis, SIRT4 deacetylates glycerol O-acyltransferase (GNPAT) and decreases its expression in HCC [200].”
Background
Metadata
- Authors
- Gu, L., Zhu, Y., Lin, X., Tan, X., Lu, B., & Li, Y.
- Affiliations
- Wuhan University (CN)
- Corresponding author
- Gu, Li
- Li, Youjun
- Venue
- Oncogene
- Published
- 2020-01-23
- Volume
- 39
- Issue
- 11
- Pages
- 2437-2449
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W3002231384
- Cited by
- 156
- References
- 41
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 45 · 2023: 31 · 2022: 20 · 2021: 10 · 2020: 6
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- ACAT1, GNPAT, fatty acid synthase, protein acetylation, TRIM21, SIRT4, ubiquitination, protein degradation, lipid metabolism, hepatocellular carcinoma, hepatocarcinogenesis, palmitic acid, sorafenib combination therapy
- MeSH terms
- Acetyl-CoA C-Acetyltransferase, Acetylation, Animals, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Up-Regulation, Palmitic Acid, Cell Line, Tumor, Lipid Metabolism, Mice, Fatty Acid Synthase, Type I, Hep G2 Cells, HEK293 Cells, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. https://app.cochat.ai/papers/10.1038/s41388-020-1156-0
- The paper
- Gu, L., Zhu, Y., Lin, X., Tan, X., Lu, B., & Li, Y. (2020). Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. https://doi.org/10.1038/s41388-020-1156-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.